Home » Newsletters » BioWorld

BioWorld

May 1, 1995

View Archived Issues

APPONITMENTS AND ADVANCEMENTS

LIPOSOME CO. COMPLETES PUBLIC OFFERING THAT NETS $25M

ALLIANCE PHARMACEUTICALS RAISES $14.5M IN PUBLIC OFFERING

FIRST CLINICAL TRIAL OF FUSION TOXIN TARGETS T CELLS IN PSORIASIS,

PHARMACEUTICAL EXECUTIVES CONTINUE PUSH FOR PRODUCT LIABILITY REFORM

AGOURON'S PROTEASE INHIBITOR SHOWS ANTI-HIV ACTIVITY